The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells
Open Access
- 25 May 1995
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 92 (1) , 77-82
- https://doi.org/10.1016/0304-3835(95)03765-o
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Intracellular Receptors Mediate the Biologic Action of 1,25-Dihydroxyvitamin D3Nutrition Reviews, 2009
- 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclonesMolecular and Cellular Endocrinology, 1993
- Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.Endocrinology, 1993
- Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolismBlood, 1991
- Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilizationBlood, 1989
- 1,25(OH) 2 ‐Vitamin D 3 receptors: gene regulation and genetic circuitryThe FASEB Journal, 1988
- Effect of 1,25-dihydroxyvitamin D3 on human cancer cells in vitroJournal of Steroid Biochemistry, 1987
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.The Journal of cell biology, 1984